Cargando…

The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol

BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septica...

Descripción completa

Detalles Bibliográficos
Autores principales: Waterfield, Thomas, Lyttle, Mark D., Fairley, Derek, Mckenna, James, Woolfall, Kerry, Lynn, Fiona, Maney, Julie-Ann, Roland, Damian, Weir, Aoife, Shields, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065062/
https://www.ncbi.nlm.nih.gov/pubmed/30060751
http://dx.doi.org/10.1186/s12887-018-1220-x
_version_ 1783342801181736960
author Waterfield, Thomas
Lyttle, Mark D.
Fairley, Derek
Mckenna, James
Woolfall, Kerry
Lynn, Fiona
Maney, Julie-Ann
Roland, Damian
Weir, Aoife
Shields, Michael D.
author_facet Waterfield, Thomas
Lyttle, Mark D.
Fairley, Derek
Mckenna, James
Woolfall, Kerry
Lynn, Fiona
Maney, Julie-Ann
Roland, Damian
Weir, Aoife
Shields, Michael D.
author_sort Waterfield, Thomas
collection PubMed
description BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septicaemia. A paucity of definitive diagnostic testing creates diagnostic uncertainty for clinicians; a safe approach mandates children without invasive disease are often admitted and treated with broad-spectrum antibiotics. Conversely, a cohort of children still experience significant mortality and morbidity due to late diagnosis. Current management is based on evidence which predates (i) the introduction of meningococcal B and C vaccines and (ii) availability of point of care testing (POCT) for procalcitonin (PCT) and Neisseria meningitidis DNA. METHODS: This PiC study is a prospective diagnostic accuracy study evaluating (i) rapid POCT for PCT and N. meningitidis DNA and (ii) performance of existing clinical practice guidelines (CPG) for feverish children with non-blanching rash. All children presenting to the ED with a history of fever and non-blanching rash are eligible. Children are managed as normal, with detailed prospective collection of data pertinent to CPGs, and a throat swab and blood used for rapid POCT. The study is running over 2 years and aims to recruit 300 children. Primary objective: Report on the diagnostic accuracy of POCT for (i) N. meningitidis DNA and (ii) PCT in the diagnosis of early MD. Report on the diagnostic accuracy of POCT for PCT in the diagnosis of Invasive bacterial infection. Secondary objectives: Evaluate the performance accuracy of existing CPGs. Evaluate cost-effectiveness of available diagnostic testing strategies. Explore views of (i) families and (ii) clinicians on research without prior consent using qualitative methodology. Report on the aetiology of NBRs in children with a feverish illness. DISCUSSION: The PiC study will provide important information for policy makers regarding the value of POCT and on the utility and cost of emerging diagnostic strategies. The study will also identify which elements of existing CPGs may merit inclusion in any future study to derive clinical decision rules for this population. TRIAL REGISTRATION: NCT03378258. Retrospectively registered on December 19, 2017.
format Online
Article
Text
id pubmed-6065062
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60650622018-08-01 The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol Waterfield, Thomas Lyttle, Mark D. Fairley, Derek Mckenna, James Woolfall, Kerry Lynn, Fiona Maney, Julie-Ann Roland, Damian Weir, Aoife Shields, Michael D. BMC Pediatr Study Protocol BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septicaemia. A paucity of definitive diagnostic testing creates diagnostic uncertainty for clinicians; a safe approach mandates children without invasive disease are often admitted and treated with broad-spectrum antibiotics. Conversely, a cohort of children still experience significant mortality and morbidity due to late diagnosis. Current management is based on evidence which predates (i) the introduction of meningococcal B and C vaccines and (ii) availability of point of care testing (POCT) for procalcitonin (PCT) and Neisseria meningitidis DNA. METHODS: This PiC study is a prospective diagnostic accuracy study evaluating (i) rapid POCT for PCT and N. meningitidis DNA and (ii) performance of existing clinical practice guidelines (CPG) for feverish children with non-blanching rash. All children presenting to the ED with a history of fever and non-blanching rash are eligible. Children are managed as normal, with detailed prospective collection of data pertinent to CPGs, and a throat swab and blood used for rapid POCT. The study is running over 2 years and aims to recruit 300 children. Primary objective: Report on the diagnostic accuracy of POCT for (i) N. meningitidis DNA and (ii) PCT in the diagnosis of early MD. Report on the diagnostic accuracy of POCT for PCT in the diagnosis of Invasive bacterial infection. Secondary objectives: Evaluate the performance accuracy of existing CPGs. Evaluate cost-effectiveness of available diagnostic testing strategies. Explore views of (i) families and (ii) clinicians on research without prior consent using qualitative methodology. Report on the aetiology of NBRs in children with a feverish illness. DISCUSSION: The PiC study will provide important information for policy makers regarding the value of POCT and on the utility and cost of emerging diagnostic strategies. The study will also identify which elements of existing CPGs may merit inclusion in any future study to derive clinical decision rules for this population. TRIAL REGISTRATION: NCT03378258. Retrospectively registered on December 19, 2017. BioMed Central 2018-07-30 /pmc/articles/PMC6065062/ /pubmed/30060751 http://dx.doi.org/10.1186/s12887-018-1220-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Waterfield, Thomas
Lyttle, Mark D.
Fairley, Derek
Mckenna, James
Woolfall, Kerry
Lynn, Fiona
Maney, Julie-Ann
Roland, Damian
Weir, Aoife
Shields, Michael D.
The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title_full The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title_fullStr The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title_full_unstemmed The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title_short The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
title_sort “petechiae in children” (pic) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for procalcitonin & neisseria meningitidis dna – a study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065062/
https://www.ncbi.nlm.nih.gov/pubmed/30060751
http://dx.doi.org/10.1186/s12887-018-1220-x
work_keys_str_mv AT waterfieldthomas thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT lyttlemarkd thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT fairleyderek thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT mckennajames thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT woolfallkerry thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT lynnfiona thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT maneyjulieann thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT rolanddamian thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT weiraoife thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT shieldsmichaeld thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT waterfieldthomas petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT lyttlemarkd petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT fairleyderek petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT mckennajames petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT woolfallkerry petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT lynnfiona petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT maneyjulieann petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT rolanddamian petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT weiraoife petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT shieldsmichaeld petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol
AT petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol